{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:22:09Z","timestamp":1791649329087,"version":"4.3.4"},"reference-count":267,"publisher":"Elsevier","isbn-type":[{"value":"9780443345197","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apcsb.2025.09.001","type":"book-chapter","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:27:03Z","timestamp":1761125223000},"page":"245-311","source":"Crossref","is-referenced-by-count":2,"title":["Bacteriophage endolysins: A promising therapeutic strategy against drug- resistant Staphylococcus aureus"],"prefix":"10.1016","member":"78","reference":[{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib1","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s00253-012-4252-4","article-title":"Staphylococcal Phage 2638A endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain secondary translational start site","volume":"97","author":"Abaev","year":"2013","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10930-023-10145-1","article-title":"Staphylococcus aureus Bacteriophage 52 Endolysin Exhibits Anti-Biofilm and Broad Antibacterial Activity Against Gram-Positive Bacteria","volume":"42","author":"Abdurahman","year":"2023","journal-title":"The Protein Journal"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1044143","article-title":"Bacteriophage-encoded lethal membrane disruptors: Advances in understanding and potential applications","volume":"13","author":"Abeysekera","year":"2022","journal-title":"Frontiers in Microbiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib4","article-title":"Meta-meta-analysis of the mortality risk associated with MRSA compared to MSSA bacteraemia","volume":"32","author":"Adeiza","year":"2024","journal-title":"Le Infezioni in Medicina"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib5","doi-asserted-by":"crossref","first-page":"104067","DOI":"10.1016\/j.fm.2022.104067","article-title":"Deletion of the amidase domain of endolysin LysRODI enhances antistaphylococcal activity in milk and during fresh cheese production","volume":"107","author":"Ag\u00fan","year":"2022","journal-title":"Food Microbiology"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.09.001_bib6","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.3390\/ijms26094376","article-title":"Modifying pharmacokinetic properties of the gram-negative bacteria targeting endolysin ML06 without affecting antibacterial activity","volume":"26","author":"Antonova","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib7","doi-asserted-by":"crossref","DOI":"10.4161\/viru.2.5.17724","article-title":"Staphylococcus aureus biofilms","volume":"2","author":"Archer","year":"2011","journal-title":"Virulence"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/antibiotics10060722","article-title":"Engineering of the CHAPk staphylococcal phage endolysin to enhance antibacterial activity against stationary-phase cells","volume":"10","author":"Arroyo-Moreno","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12866-023-03002-9","article-title":"LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus","volume":"23","author":"Asadi","year":"2023","journal-title":"BMC Microbiology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02176-19","article-title":"Synergistic activity of exebacase (CF-301) in addition to daptomycin against staphylococcus aureus in a neutropenic murine thigh infection model","volume":"64","author":"Asempa","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.09.001_bib11","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1093\/jac\/dkab206","article-title":"Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model","volume":"76","author":"Asempa","year":"2021","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02009-18","article-title":"Efficacy of intranasal administration of the recombinant endolysin SAL200 in a lethal murine staphylococcus aureus pneumonia model","volume":"63","author":"Bae","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/S0968-0004(03)00061-6","article-title":"The CHAP domain: A large family of amidases including GSP amidase and peptidoglycan hydrolases","volume":"28","author":"Bateman","year":"2003","journal-title":"Trends in Biochemical Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1574-6968.2009.01541.x","article-title":"LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells","volume":"294","author":"Becker","year":"2009","journal-title":"FEMS Microbiology Letters"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1574-6968.2008.01308.x","article-title":"The phage k lytic enzyme LysK and lysostaphin act synergistically to kill MRSA","volume":"287","author":"Becker","year":"2008","journal-title":"FEMS Microbiology Letters"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2025.09.001_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gene.2009.04.023","article-title":"Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain","volume":"443","author":"Becker","year":"2009","journal-title":"Gene"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsle\/fnu019","article-title":"Lytic activity of the staphylolytic twort phage endolysin CHAP domain is enhanced by the SH3b cell wall binding domain","volume":"362","author":"Becker","year":"2015","journal-title":"FEMS Microbiology Letters"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127969","article-title":"Expression and characterization of novel chimeric endolysin CHAPk-SH3bk against biofilm-forming methicillin-resistant staphylococcus aureus","volume":"254","author":"Behera","year":"2024","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1397935","article-title":"Phage endolysins as new therapeutic options for multidrug resistant staphylococcus aureus: An emerging antibiotic-free way to combat drug resistant infections","volume":"14","author":"Belete","year":"2024","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01379-14","article-title":"Engineered endolysin-based \u201cartilysins\u201d to combat multidrug-resistant gram-negative pathogens","volume":"5","author":"Briers","year":"2014","journal-title":"mBio"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/mmi.14134","article-title":"Catalytic diversity and cell wall binding repeats in the phage-encoded endolysins","volume":"110","author":"Broendum","year":"2018","journal-title":"Molecular Microbiology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/13543784.2022.2040015","article-title":"Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Progress in clinical trials","volume":"31","author":"Burgin","year":"2022","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108250","article-title":"Design strategies for positively charged endolysins: Insights into artilysin development","volume":"69","author":"Carratal\u00e1","year":"2023","journal-title":"Biotechnology Advances"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib24","doi-asserted-by":"crossref","first-page":"103245","DOI":"10.1016\/j.fm.2019.103245","article-title":"Effective removal of staphylococcal biofilms on various food contact surfaces by Staphylococcus aureus phage endolysin LysCSA13","volume":"84","author":"Cha","year":"2019","journal-title":"Food Microbiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib25","doi-asserted-by":"crossref","DOI":"10.3201\/eid0702.010204","article-title":"The changing epidemiology of staphylococcus aureus?","volume":"7","author":"Chambers","year":"2001","journal-title":"Emerging Infectious Diseases"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.09.001_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nature Reviews. Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib27","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.12648","article-title":"Lactococcus lactis secreting phage lysins as a potential antimicrobial against multi-drug resistant Staphylococcus aureus","volume":"10","author":"Chandran","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fm.2017.07.004","article-title":"Characterization of a novel endolysin LysSA11 and its utility as a potent biocontrol agent against Staphylococcus aureus on food and utensils","volume":"68","author":"Chang","year":"2017","journal-title":"Food Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib29","doi-asserted-by":"crossref","first-page":"144676","DOI":"10.1016\/j.ijbiomac.2025.144676","article-title":"Cloning and characterization of the lysis protein LysSGF3 from Shigella Microviridae phage SGF3 for control of pathogenic bacteria and biofilms","volume":"316","author":"Chang","year":"2025","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00253-016-7747-6","article-title":"Characterization of a novel cell wall binding domain-containing Staphylococcus aureus endolysin LysSA97","volume":"101","author":"Chang","year":"2017","journal-title":"Applied Microbiology and Biotechnology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijfoodmicro.2016.12.007","article-title":"Endolysin LysSA97 is synergistic with carvacrol in controlling Staphylococcus aureus in foods","volume":"244","author":"Chang","year":"2017","journal-title":"International Journal of Food Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dky365","article-title":"Efficacy of chimeric ectolysin P128 in drug-resistant staphylococcus aureus bacteraemia in mice","author":"Channabasappa","year":"2018","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/v10050244","article-title":"An ointment consisting of the phage lysin LysGH15 and apigenin for decolonization of Methicillin-resistant staphylococcus aureus from skin wounds","volume":"10","author":"Cheng","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1039\/C3AN01608K","article-title":"Immobilized phage proteins for specific detection of staphylococci","volume":"139","author":"Chibli","year":"2014","journal-title":"The Analyst"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib35","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.4014\/jmb.2402.02042","article-title":"A Novel Truncated CHAP Modular Endolysin, CHAP SAP26-161, That Lyses Staphylococcus aureus, Acinetobacter baumannii, and Clostridioides difficile, and Exhibits Therapeutic Effects in a Mouse Model of A. baumannii Infection","volume":"34","author":"Choi","year":"2024","journal-title":"Journal of Microbiology and Biotechnology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.09.001_bib36","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s00253-015-6460-1","article-title":"Potential of sequential treatment with minocycline and S. Aureus specific phage lysin in eradication of MRSA biofilms: An in vitro study","volume":"99","author":"Chopra","year":"2015","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijmm.2016.08.003","article-title":"Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice","volume":"306","author":"Chopra","year":"2016","journal-title":"International Journal of Medical Microbiology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib38","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1021\/acssynbio.9b00360","article-title":"Yeast surface display system for facilitated production and application of phage endolysin","volume":"9","author":"Chun","year":"2020","journal-title":"ACS Synthetic Biology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.19.2.403-434.2006","article-title":"Burn wound infections","volume":"19","author":"Church","year":"2006","journal-title":"Clinical Microbiology Reviews"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib40","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1128\/AAC.01625-09","article-title":"Synergism between a novel chimeric lysin and oxacillin protects against infection by Methicillin-resistant Staphylococcus aureus","volume":"54","author":"Daniel","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.09.001_bib41","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/antibiotics10121497","article-title":"Treating bacterial infections with Bacteriophage-based enzybiotics: In vitro, in vivo and clinical application","volume":"10","author":"Danis-Wlodarczyk","year":"2021","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clinical Microbiology Reviews"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1751-7915.12166","article-title":"Construction of a chimeric lysin<scp>Ply187N<\/scp>\u2010<scp>V12C<\/scp>with extended lytic activity against staphylococci and streptococci","volume":"8","author":"Dong","year":"2015","journal-title":"Microbial Biotechnology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/187220807780809463","article-title":"Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications","volume":"1","author":"Donovan","year":"2007","journal-title":"Recent Patents on Biotechnology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib45","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1128\/AEM.72.4.2988-2996.2006","article-title":"Peptidoglycan hydrolase fusions maintain their parental specificities","volume":"72","author":"Donovan","year":"2006","journal-title":"Applied and Environmental Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1574-6968.2008.01287.x","article-title":"LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci","volume":"287","author":"Donovan","year":"2008","journal-title":"FEMS Microbiology Letters"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.2006.00483.x","article-title":"Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin: Lysis of staphylococcal mastitis pathogens","volume":"265","author":"Donovan","year":"2006","journal-title":"FEMS Microbiology Letters"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05050-22","article-title":"Exploiting Broad-Spectrum Chimeric Lysin to Cooperate with Mupirocin against Staphylococcus aureus-Induced Skin Infections and Delay the Development of Mupirocin Resistance","volume":"11","author":"Duan","year":"2023","journal-title":"Microbiology Spectrum"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02273-21","article-title":"Linker-improved chimeric endolysin selectively kills staphylococcus aureus In Vitro, on reconstituted human epidermis, and in a murine model of skin infection","volume":"66","author":"Eichenseher","year":"2022","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2958.2011.07774.x","article-title":"The cell wall binding domain of listeria bacteriophage endolysin PlyP35 recognizes terminal GlcNAc residues in cell wall teichoic acid","volume":"81","author":"Eugster","year":"2011","journal-title":"Molecular Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vetmic.2016.06.001","article-title":"Preliminary treatment of bovine mastitis caused by Staphylococcus aureus, with trx-SA1, recombinant endolysin of S. aureus bacteriophage IME-SA1","volume":"191","author":"Fan","year":"2016","journal-title":"Veterinary Microbiology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib52","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4161\/bbug.1.6.13422","article-title":"The truncated phage lysin CHAP","volume":"1","author":"Fenton","year":"2010","journal-title":"Bioengineered Bugs"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/mdr.2012.0025","article-title":"Novel chimerical endolysins with broad antimicrobial activity against Methicillin-resistantStaphylococcus aureus","volume":"18","author":"Fernandes","year":"2012","journal-title":"Microbial Drug Resistance"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02724-16","article-title":"Downregulation of autolysin-encoding genes by phage-derived lytic proteins inhibits biofilm formation in staphylococcus aureus","volume":"61","author":"Fern\u00e1ndez","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.biochi.2019.04.005","article-title":"Kinetics of inactivation of staphylolytic enzymes: Qualitative and quantitative description","volume":"162","author":"Filatova","year":"2019","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2005.09.082","article-title":"Crystal structures of active LytM","volume":"354","author":"Firczuk","year":"2005","journal-title":"Journal of Molecular Biology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.09.001_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2005.08.007","article-title":"Bacteriophage lytic enzymes: Novel anti-infectives","volume":"13","author":"Fischetti","year":"2005","journal-title":"Trends in Microbiology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijmm.2010.04.002","article-title":"Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens","volume":"300","author":"Fischetti","year":"2010","journal-title":"International Journal of Medical Microbiology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.09.001_bib59","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1172\/JCI136577","article-title":"Exebacase for patients with staphylococcus aureus bloodstream infection and endocarditis","volume":"130","author":"Fowler","year":"2020","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib60","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/cid\/ciae043","article-title":"Exebacase in addition to Standard-of-Care antibiotics for Staphylococcus aureus bloodstream infections and right-sided infective endocarditis: A phase 3, superiority-design, Placebo-controlled, randomized clinical trial (DISRUPT)","volume":"78","author":"Fowler","year":"2024","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib61","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/bs.apcsb.2022.10.004","article-title":"Secretory proteins in the orchestration of microbial virulence: The curious case of Staphylococcus aureus","volume":"133","author":"Francis","year":"2023"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib62","doi-asserted-by":"crossref","DOI":"10.5114\/bta.2021.103761","article-title":"Identification of CD4+ T cell epitopes from staphylococcus aureus secretome using immunoinformatic prediction and molecular docking","volume":"102","author":"Francis","year":"2021","journal-title":"BioTechnologia"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib63","doi-asserted-by":"crossref","DOI":"10.5114\/ceji.2018.81348","article-title":"Immunogenicity and protective efficacy of recombinant alkaline shock protein 23 from staphylococcus aureus in a murine model","volume":"43","author":"Francis","year":"2018","journal-title":"Central-European Journal of Immunology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib64","series-title":"Microbial enzymes as potential biotherapeutics in human healthcare","article-title":"Enzybiotics: An emerging frontier in antibacterial therapy","author":"Francis","year":"2025"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib65","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/bs.apcsb.2023.08.002","article-title":"The biofilm proteome of Staphylococcus aureus and its implications for therapeutic interventions to biofilm-associated infections","volume":"138","author":"Francis","year":"2024"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/ph11010025","article-title":"Characterization of the lytic capability of a LysK-like endolysin, Lys-phiSA012, derived from a polyvalent staphylococcus aureus bacteriophage","volume":"11","author":"Fujiki","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib67","doi-asserted-by":"crossref","DOI":"10.1007\/s12602-025-10543-0","article-title":"Characteristics and antibacterial activity of staphylococcus aureus phage-derived endolysin LysP4","author":"Gao","year":"2025","journal-title":"Probiotics and Antimicrobial Proteins"},{"issue":"24","key":"10.1016\/bs.apcsb.2025.09.001_bib68","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1128\/AEM.01864-09","article-title":"Functional genomic analysis of two Staphylococcus aureus phages isolated from the dairy environment","volume":"75","author":"Garc\u00eda","year":"2009","journal-title":"Applied and Environmental Microbiology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijfoodmicro.2010.04.029","article-title":"Synergy between the phage endolysin LysH5 and nisin to kill staphylococcus aureus in pasteurized milk","volume":"141","author":"Garc\u00eda","year":"2010","journal-title":"International Journal of Food Microbiology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib70","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01813-23","article-title":"Distinct mode of action of a highly stable, engineered phage lysin killing Gram-negative bacteria","volume":"11","author":"Gerstmans","year":"2023","journal-title":"Microbiology Spectrum"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib71","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.02526-12","article-title":"Novel bacteriophage lysin with broad lytic activity protects against mixed infection by streptococcus pyogenes and Methicillin-resistant staphylococcus aureus","volume":"57","author":"Gilmer","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40121-024-01069-z","article-title":"Phage-derived endolysins against resistant staphylococcus spp.: A review of features, antibacterial activities, and recent applications","volume":"14","author":"Golban","year":"2025","journal-title":"Infectious Diseases and Therapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/v16010093","article-title":"Characterization of a Thermostable Endolysin of the Aeribacillus Phage AeriP45 as a Potential Staphylococcus Biofilm-Removing Agent","volume":"16","author":"Golosova","year":"2024","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib74","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/v16030385","article-title":"Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological Agents","volume":"16","author":"Golosova","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib75","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/s41598-022-05361-1","article-title":"Synthetic antimicrobial peptides as enhancers of the bacteriolytic action of staphylococcal phage endolysins","volume":"12","author":"Gouveia","year":"2022","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib76","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/ijms25010523","article-title":"Cellular and enzymatic determinants impacting the exolytic action of an anti-Staphylococcal enzybiotic","volume":"25","author":"Gouveia","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-80961-x","article-title":"An in vitro study on staphylococcus schweitzeri virulence","volume":"11","author":"Grossmann","year":"2021","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004109","article-title":"Structural and biochemical characterization reveals LysGH15 as an unprecedented \u201cEF-Hand-Like\u201d Calcium-binding phage lysin","volume":"10","author":"Gu","year":"2014","journal-title":"PLoS Pathogens"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib79","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00284-011-0018-y","article-title":"LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci","volume":"63","author":"Gu","year":"2011","journal-title":"Current Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib80","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/JCM.01144-10","article-title":"LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal Methicillin-resistant Staphylococcus aureus infection","volume":"49","author":"Gu","year":"2011","journal-title":"Journal of Clinical Microbiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib81","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4161\/bbug.2.2.14883","article-title":"LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice","volume":"2","author":"Gu","year":"2011","journal-title":"Bioengineered Bugs"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib82","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1007\/s00253-015-7185-x","article-title":"The potential of the endolysin lysdb from lactobacillus delbrueckii phage for combating staphylococcus aureus during cheese manufacture from raw milk","volume":"100","author":"Guo","year":"2016","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib83","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00284-010-9699-x","article-title":"Efficacy of polyvalent bacteriophage P-27\/HP to control multidrug resistant staphylococcus aureus associated with human infections","volume":"62","author":"Gupta","year":"2011","journal-title":"Current Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib84","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3389\/fmicb.2017.01632","article-title":"Real-time assessment of staphylococcus aureus biofilm disruption by phage-derived proteins","volume":"8","author":"Guti\u00e9rrez","year":"2017","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib85","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmicb.2020.00007","article-title":"Phage lytic protein LysRODI prevents staphylococcal mastitis in mice","volume":"11","author":"Guti\u00e9rrez","year":"2020","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.723834","article-title":"Design and selection of engineered lytic proteins with staphylococcus aureus decolonizing activity","volume":"12","author":"Guti\u00e9rrez","year":"2021","journal-title":"Frontiers in Microbiology"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.09.001_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107307","article-title":"Effective removal of staphylococcal biofilms by the endolysin LysH5","volume":"9","author":"Guti\u00e9rrez","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00290","article-title":"A novel chimeric endolysin with antibacterial activity against Methicillin-resistant staphylococcus aureus","volume":"7","author":"Haddad Kashani","year":"2017","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00071-17","article-title":"Recombinant endolysins as potential therapeutics against antibiotic-resistant staphylococcus aureus: Current status of research and novel delivery strategies","volume":"31","author":"Haddad Kashani","year":"2018","journal-title":"Clinical Microbiology Reviews"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib90","doi-asserted-by":"crossref","DOI":"10.1007\/s44337-025-00300-1","article-title":"Current status and recent trends in innovative tactics and the one health approach to address the challenge of methicillin-resistant staphylococcus aureus infections: A comprehensive review","volume":"2","author":"Hajhamed","year":"2025","journal-title":"Discover Medicine"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.030","article-title":"Thermally triggered release of the bacteriophage endolysin CHAPK and the bacteriocin lysostaphin for the control of methicillin resistant staphylococcus aureus (MRSA)","volume":"245","author":"Hathaway","year":"2017","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.783472","article-title":"In-situ and real-time monitoring of the interaction between lysins and staphylococcus aureus biofilm by surface plasmon resonance","volume":"12","author":"Hong","year":"2021","journal-title":"Frontiers in Microbiology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib93","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/AEM.01831-08","article-title":"Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci","volume":"75","author":"Horgan","year":"2009","journal-title":"Applied and Environmental Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib94","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00430-019-00638-1","article-title":"Comparative in vitro activity of bacteriophage endolysin HY-133 against Staphylococcus aureus attached to vascular graft surface","volume":"209","author":"Idelevich","year":"2020","journal-title":"Medical Microbiology and Immunology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib95","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1128\/AAC.02859-15","article-title":"The recombinant bacteriophage endolysin HY-133 exhibits In Vitro activity against different African clonal lineages of the staphylococcus aureus complex, including staphylococcus schweitzeri","volume":"60","author":"Idelevich","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.09.001_bib96","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1128\/AAC.00217-11","article-title":"In Vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin","volume":"55","author":"Idelevich","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.09.001_bib97","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3390\/v11090769","article-title":"Therapeutic potential of an endolysin derived from Kayvirus S25-3 for Staphylococcal Impetigo","volume":"11","author":"Imanishi","year":"2019","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib98","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02291-18","article-title":"The antistaphylococcal lysin, CF-301, activates key host factors in human blood to potentiate Methicillin-resistantStaphylococcus aureusBacteriolysis","volume":"63","author":"Indiani","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib99","unstructured":"Intron Biotechnology, Inc. (2021). A randomized, double-blind, Placebo-controlled, multicenter phase IIa clinical study to evaluate safety and to explore efficacy of N-Rephasin\u00ae SAL200, in patients with persistent Staphylococcus aureus Bacteremia (Clinical Trial Registration No. NCT03089697). clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT03089697."},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02629-16","article-title":"Pharmacokinetics and tolerance of the phage endolysin-based candidate drug SAL200 after a single intravenous administration among healthy volunteers","volume":"61","author":"Jun","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib101","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/AAC.01097-10","article-title":"Comparison of the antibacterial properties of phage endolysins SAL-1 and LysK","volume":"55","author":"Jun","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib102","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2012.10.011","article-title":"Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1","volume":"41","author":"Jun","year":"2013","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib103","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/AAC.02232-13","article-title":"Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient","volume":"58","author":"Jun","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.09.001_bib104","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/1440-1681.12613","article-title":"Pharmacokinetics of the phage endolysin\u2010based candidate drug SAL 200 in monkeys and its appropriate intravenous dosing period","volume":"43","author":"Jun","year":"2016","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13104-023-06468-y","article-title":"In vitro activity of exebacase against methicillin-resistant staphylococcus aureus biofilms on orthopedic kirschner wires","volume":"16","author":"Karau","year":"2023","journal-title":"BMC Research Notes"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib106","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00117-21","article-title":"Activity of lysin CF-296 alone and in addition to daptomycin in a rat model of experimental Methicillin-resistant staphylococcus aureus osteomyelitis","volume":"65","author":"Karau","year":"2021","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib107","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5194\/jbji-7-169-2022","article-title":"Locally delivered antistaphylococcal lysin exebacase or CF-296 is active in methicillin-resistant Staphylococcus aureus implant-associated osteomyelitis","volume":"7","author":"Karau","year":"2022","journal-title":"Journal of Bone and Joint Infection"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.09.001_bib108","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01235-19","article-title":"Exebacase in addition to daptomycin is more active than daptomycin or exebacase alone in Methicillin-resistant staphylococcus aureus osteomyelitis in rats","volume":"63","author":"Karau","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.09.001_bib109","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00385-18","article-title":"The novel phage-derived antimicrobial agent HY-133 is active against livestock-associated Methicillin-resistant staphylococcus aureus","volume":"62","author":"Kaspar","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11262-020-01762-4","article-title":"A potent enzybiotic against methicillin-resistant staphylococcus aureus","volume":"56","author":"Kaur","year":"2020","journal-title":"Virus Genes"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib111","doi-asserted-by":"crossref","DOI":"10.4161\/bact.28451","article-title":"Genome analysis of the staphylococcal temperate phage DW2 and functional studies on the endolysin and tail hydrolase","volume":"4","author":"Keary","year":"2014","journal-title":"Bacteriophage"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.09.001_bib112","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00128-21","article-title":"Exebacase in addition to daptomycin against MRSA","volume":"65","author":"Kebriaei","year":"2021","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1385261","article-title":"Endolysins: A new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria","volume":"15","author":"Khan","year":"2024","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib114","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jgar.2020.01.005","article-title":"Antimicrobial activity of LysSS, a novel phage endolysin, against acinetobacter baumannii and pseudomonas aeruginosa","volume":"22","author":"Kim","year":"2020","journal-title":"Journal of Global Antimicrobial Resistance"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.09.001_bib115","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00731-18","article-title":"Effects of phage endolysin SAL200 combined with antibiotics on staphylococcus aureus infection","volume":"62","author":"Kim","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib116","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.diagmicrobio.2018.11.005","article-title":"Bactericidal activity of bacteriophage endolysin HY-133 against staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time-kill analysis","volume":"93","author":"Knaack","year":"2019","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib117","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jac\/dkm347","article-title":"Lysostaphin as a treatment for systemic staphylococcus aureus infection in a mouse model","volume":"60","author":"Kokai-Kun","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib118","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3934\/microbiol.2019.2.158","article-title":"Antimicrobial activity of bacteriophage derived triple fusion protein against Staphylococcus aureus","volume":"5","author":"Kovalskaya","year":"2019","journal-title":"AIMS Microbiology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib119","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02402-06","article-title":"Use of high-affinity cell wall-binding domains of bacteriophage endolysins for immobilization and separation of bacterial cells","volume":"73","author":"Kretzer","year":"2007","journal-title":"Applied and Environmental Microbiology"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.09.001_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro.2017.104","article-title":"The commensal lifestyle of staphylococcus aureus and its interactions with the nasal microbiota","volume":"15","author":"Krismer","year":"2017","journal-title":"Nature Reviews. Microbiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib121","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/08927014.2021.1887151","article-title":"The novel endolysin XZ.700 effectively treats MRSA biofilms in two biofilm models without showing toxicity on human bone cells in vitro","volume":"37","author":"Kuiper","year":"2021","journal-title":"Biofouling"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib122","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00253-011-3104-y","article-title":"Antibacterial activity of acinetobacter baumannii phage \u03d5AB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria","volume":"90","author":"Lai","year":"2011","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib123","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0029-2018","article-title":"Staphylococcus aureus colonization of the human nose and interaction with other microbiome members","volume":"7","author":"Laux","year":"2019","journal-title":"Microbiology Spectrum"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib124","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1021\/acsinfecdis.0c00812","article-title":"Development of advanced chimeric endolysin to control multidrug-resistant staphylococcus aureus through domain shuffling","volume":"7","author":"Lee","year":"2021","journal-title":"ACS Infectious Diseases"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib125","doi-asserted-by":"crossref","first-page":"104710","DOI":"10.1016\/j.fm.2024.104710","article-title":"The food application of a novel Staphylococcus aureus bacteriophage vB_SA_STAP152 and its endolysin LysP152 with high enzymatic activity under cold temperature","volume":"128","author":"Li","year":"2025","journal-title":"Food Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib126","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-025-01457-4","article-title":"Development of a novel chimeric lysin to combine parental phage lysin and cefquinome for preventing sow endometritis after artificial insemination","volume":"56","author":"Li","year":"2025","journal-title":"Veterinary Research"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib127","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/antibiotics10040461","article-title":"A highly active chimeric lysin with a calcium-enhanced bactericidal activity against staphylococcus aureus In Vitro and In Vivo","volume":"10","author":"Li","year":"2021","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib128","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: An alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World Journal of Gastrointestinal Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00253-014-5930-1","article-title":"Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant staphylococcus aureus","volume":"99","author":"Linden","year":"2015","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-023-00919-1","article-title":"Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria","volume":"30","author":"Liu","year":"2023","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib131","article-title":"Bacteriophage therapy for drug-resistant staphylococcus aureus infections","volume":"14","author":"Liu","year":"2024","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib132","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12934-024-02359-4","article-title":"LysSYL: A broad-spectrum phage endolysin targeting staphylococcus species and eradicating S. Aureus biofilms","volume":"23","author":"Liu","year":"2024","journal-title":"Microbial Cell Factories"},{"issue":"5549","key":"10.1016\/bs.apcsb.2025.09.001_bib133","doi-asserted-by":"crossref","DOI":"10.1126\/science.1066869","article-title":"Rapid killing of streptococcus pneumoniae with a bacteriophage cell wall hydrolase","volume":"294","author":"Loeffler","year":"2001","journal-title":"Science (New York, N. Y.)"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2005.06.002","article-title":"Bacteriophage endolysins\u2014current state of research and applications","volume":"8","author":"Loessner","year":"2005","journal-title":"Current Opinion in Microbiology"},{"issue":"15","key":"10.1016\/bs.apcsb.2025.09.001_bib135","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1128\/JB.181.15.4452-4460.1999","article-title":"Evidence for a Holin-like protein gene fully embedded out of frame in the endolysin gene of Staphylococcus aureus bacteriophage 187","volume":"181","author":"Loessner","year":"1999","journal-title":"Journal of Bacteriology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib136","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1574-6968.1998.tb13008.x","article-title":"The two-component endolysis system of Staphylococcus aureus bacteriophage twort: A large TTG-start holin and an associated amidase lysin","volume":"162","author":"Loessner","year":"1998","journal-title":"FEMS Microbiology Letters"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib137","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib138","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ijbiomac.2019.10.065","article-title":"Cloning and characterization of endolysin and holin from Streptomyces avermitilis bacteriophage phiSASD1 as potential novel antibiotic candidates","volume":"147","author":"Lu","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.668430","article-title":"Phage endolysin LysP108 showed promising antibacterial potential against Methicillin-resistant staphylococcus aureus","volume":"11","author":"Lu","year":"2021","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.09.001_bib140","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.3390\/pharmaceutics15102511","article-title":"Resensitisation of methicillin-resistant staphylococcus aureus to conventional antibiotics in the presence of an engineered enzybiotic","volume":"15","author":"Manoharadas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.09.001_bib141","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/life11121384","article-title":"An engineered multimodular enzybiotic against methicillin-resistant staphylococcus aureus","volume":"11","author":"Manoharadas","year":"2021","journal-title":"Life"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib142","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jbiotec.2008.09.003","article-title":"Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus","volume":"139","author":"Manoharadas","year":"2009","journal-title":"Journal of Biotechnology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib143","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/1574-6968.12104","article-title":"Chimeric Ply187 endolysin killsStaphylococcus aureusmore effectively than the parental enzyme","volume":"342","author":"Mao","year":"2013","journal-title":"FEMS Microbiology Letters"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib144","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40268-022-00383-6","article-title":"Exebacase: A novel approach to the treatment of staphylococcal infections","volume":"22","author":"McCarthy","year":"2022","journal-title":"Drugs in R&D"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/v10040182","article-title":"Characterization of a new staphylococcus aureus kayvirus harboring a lysin active against biofilms","volume":"10","author":"Melo","year":"2018","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.09.001_bib146","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/pharmaceutics16121539","article-title":"Targeted antibacterial endolysin to treat infected wounds on 3D full-thickness skin model: XZ.700 efficacy","volume":"16","author":"Meloni","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5269","article-title":"Molecular basis for bacterial peptidoglycan recognition by LysM domains","volume":"5","author":"Mesnage","year":"2014","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib148","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4142\/jvs.2013.14.1.37","article-title":"Expression and lytic efficacy assessment of the Staphylococcus aureus phage SA4 lysin gene","volume":"14","author":"Mishra","year":"2013","journal-title":"Journal of Veterinary Science"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42435-z","article-title":"Structural bases of peptidoglycan recognition by lysostaphin SH3b domain","volume":"9","author":"Mitkowski","year":"2019","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13568-024-01812-2","article-title":"Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability","volume":"14","author":"Momen","year":"2024","journal-title":"AMB Express"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib151","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/ciab1015","article-title":"Safety and pharmacokinetics of exebacase in an infant with disseminated Staphylococcus aureus infection","volume":"75","author":"Moorthy","year":"2022","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.09.001_bib152","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.36849\/JDD.6363","article-title":"Topical S. Aureus\u2014targeting endolysin significantly improves symptoms and QoL in individuals with atopic dermatitis","volume":"20","author":"Moreau","year":"2021","journal-title":"Journal of Drugs in Dermatology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib153","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/v13040680","article-title":"The advantages and challenges of using endolysins in a clinical setting","volume":"13","author":"Murray","year":"2021","journal-title":"Viruses"},{"issue":"10459","key":"10.1016\/bs.apcsb.2025.09.001_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"The Lancet"},{"issue":"22","key":"10.1016\/bs.apcsb.2025.09.001_bib155","doi-asserted-by":"crossref","first-page":"15847","DOI":"10.1074\/jbc.274.22.15847","article-title":"Multiple enzymatic activities of the murein hydrolase from staphylococcal phage \u03c611","volume":"274","author":"Navarre","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib156","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/cid\/ciaa1581","article-title":"National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States","volume":"72","author":"Nelson","year":"2021","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.09.001_bib157","article-title":"Prevention and elimination of upper respiratory colonization of mice by group a streptococci by using a bacteriophage lytic enzyme","volume":"98","author":"Nelson","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib158","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/B978-0-12-394438-2.00007-4","article-title":"Endolysins as antimicrobials","volume":"83","author":"Nelson","year":"2012","journal-title":"Advances in Virus Research"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib159","doi-asserted-by":"crossref","first-page":"109809","DOI":"10.1016\/j.enzmictec.2021.109809","article-title":"Characterizations of the endolysin Lys84 and its domains from phage qdsa002 with high activities against Staphylococcus aureus and its biofilms","volume":"148","author":"Ning","year":"2021","journal-title":"Enzyme and Microbial Technology"},{"issue":"20","key":"10.1016\/bs.apcsb.2025.09.001_bib160","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/JB.187.20.7161-7164.2005","article-title":"The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including Methicillin-resistant Staphylococcus aureus","volume":"187","author":"O\u2019Flaherty","year":"2005","journal-title":"Journal of Bacteriology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib161","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/AEM.71.4.1836-1842.2005","article-title":"Potential of the polyvalent anti- Staphylococcus bacteriophage k for control of antibiotic-resistant staphylococci from hospitals","volume":"71","author":"O\u2019Flaherty","year":"2005","journal-title":"Applied and Environmental Microbiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib162","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijfoodmicro.2008.08.010","article-title":"Lytic activity of the recombinant staphylococcal bacteriophage \u03a6H5 endolysin active against staphylococcus aureus in milk","volume":"128","author":"Obeso","year":"2008","journal-title":"International Journal of Food Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100639","article-title":"The multidomain architecture of a bacteriophage endolysin enables intramolecular synergism and regulation of bacterial lysis","volume":"296","author":"Oechslin","year":"2021","journal-title":"The Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib164","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/v10080438","article-title":"Synergistic removal of static and dynamic staphylococcus aureus biofilms by combined treatment with a bacteriophage endolysin and a polysaccharide depolymerase","volume":"10","author":"Olsen","year":"2018","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.09.001_bib165","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jid.2023.01.039","article-title":"Endolysin inhibits skin colonization by patient-derived staphylococcus aureus and malignant T-Cell activation in cutaneous T-cell lymphoma","volume":"143","author":"Pallesen","year":"2023","journal-title":"Journal of Investigative Dermatology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib166","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00253-023-12979-2","article-title":"Metagenomic analysis of hot spring soil for mining a novel thermostable enzybiotic","volume":"108","author":"Pantiora","year":"2024","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib167","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10068-021-00910-2","article-title":"Characteristics for phage-encoded cell wall hydrolase of LysSAP27 to reduce staphylococcal food poisoning","volume":"30","author":"Park","year":"2021","journal-title":"Food Science and Biotechnology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib168","unstructured":"Pasmans, S.G.M.A. The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus aureus. In Patients With Atopic Dermatitis (Clinical Trial Registration No. NCT02840955), 2018. clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT02840955."},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib169","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/AAC.00890-10","article-title":"A novel chimeric lysin shows superiority to mupirocin for skin decolonization of Methicillin-resistant and -sensitive Staphylococcus aureus strains","volume":"55","author":"Pastagia","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034052","article-title":"Mycobacteriophage endolysins: Diverse and modular enzymes with multiple catalytic activities","volume":"7","author":"Payne","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib171","doi-asserted-by":"crossref","first-page":"107188","DOI":"10.1016\/j.micpath.2024.107188","article-title":"Evaluation and characterization of lytic phages and their recombinant endolysins for control of Staphylococcus aureus aiming to mitigate bovine mastitis","volume":"199","author":"Pereira","year":"2025","journal-title":"Microbial Pathogenesis"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib172","doi-asserted-by":"crossref","first-page":"5463801","DOI":"10.1155\/2020\/5463801","article-title":"Isolation of a novel lytic bacteriophage against a nosocomial methicillin\u2010resistant Staphylococcus aureus belonging to ST45","volume":"2020","author":"Pertics","year":"2020","journal-title":"BioMed Research International"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.febslet.2015.01.036","article-title":"Modulation of domain\u2013domain interaction and protein function by a charged linker: A case study of mycobacteriophage D29 endolysin","volume":"589","author":"Pohane","year":"2015","journal-title":"FEBS Letters"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib174","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/antibiotics9050242","article-title":"Encapsulation of the antistaphylococcal endolysin LysRODI in pH-Sensitive liposomes","volume":"9","author":"Portilla","year":"2020","journal-title":"Antibiotics"},{"issue":"22","key":"10.1016\/bs.apcsb.2025.09.001_bib175","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1128\/AEM.01783-07","article-title":"LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae","volume":"73","author":"Pritchard","year":"2007","journal-title":"Applied and Environmental Microbiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib176","first-page":"85","article-title":"Cysteine\/Histidine-Dependent Amidohydrolase\/Peptidase (CHAP)-Displayed nano phages: Antimicrobial function against Methicillin-Resistant Staphylococcus aureus (MRSA)","volume":"12","author":"Rahimzadeh","year":"2020","journal-title":"Avicenna Journal of Medical Biotechnology"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.09.001_bib177","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3390\/antibiotics10111277","article-title":"Endolysin, a promising solution against antimicrobial resistance","volume":"10","author":"Rahman","year":"2021","journal-title":"Antibiotics"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib178","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/521305","article-title":"Efficient elimination of Multidrug\u2010resistant Staphylococcus aureus by cloned lysin derived from bacteriophage \u03c6MR11","volume":"196","author":"Rashel","year":"2007","journal-title":"The Journal of Infectious Diseases"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.09.001_bib179","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1073\/pnas.1619249114","article-title":"Lysibodies are IgG fc fusions with lysin binding domains targetingStaphylococcus aureuswall carbohydrates for effective phagocytosis","volume":"114","author":"Raz","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/S0968-0004(03)00062-8","article-title":"Amidase domains from bacterial and phage autolysins de\ufb01ne a family of g-D,L-glutamate-speci\ufb01c amidohydrolasesq","author":"Rigden","year":"2003","journal-title":"Trends in Biochemical Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib181","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1754-6834-6-20","article-title":"Bacteriophage-encoded lytic enzymes control growth of contaminating lactobacillus found in fuel ethanol fermentations","volume":"6","author":"Roach","year":"2013","journal-title":"Biotechnology for Biofuels"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib182","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2180-11-138","article-title":"Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of staphylococcus aureusbacteriophage vB_SauS-phiIPLA88","volume":"11","author":"Rodr\u00edguez","year":"2011","journal-title":"BMC Microbiology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib183","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064671","article-title":"The phage lytic proteins from the staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance","volume":"8","author":"Rodr\u00edguez-Rubio","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib184","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02540-23","article-title":"MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infections","volume":"15","author":"Roehrig","year":"2024","journal-title":"MBio"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.09.001_bib185","doi-asserted-by":"crossref","DOI":"10.1111\/febs.12929","article-title":"Crystal structure of the antimicrobial peptidase lysostaphin from staphylococcus simulans","volume":"281","author":"Sabala","year":"2014","journal-title":"The FEBS Journal"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib186","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02419","article-title":"Staphylococcus aureus nasal colonization: An update on mechanisms, epidemiology, risk factors, and subsequent infections","volume":"9","author":"Sakr","year":"2018","journal-title":"Frontiers in Microbiology"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib187","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro3308","article-title":"Models matter: The search for an effective staphylococcus aureus vaccine","volume":"12","author":"Salgado-Pab\u00f3n","year":"2014","journal-title":"Nature Reviews. Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib188","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-39097-2","article-title":"Identification of the first endolysin cell binding domain (CBD) targeting paenibacillus larvae","volume":"9","author":"Santos","year":"2019","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.09.001_bib189","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1107\/S1744309113030133","article-title":"Crystallization of the CHAP domain of the endolysin from Staphylococcus aureus bacteriophage K","volume":"69","author":"Sanz-Gaitero","year":"2013","journal-title":"Acta Crystallographica Section F Structural Biology and Crystallization Communications"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib190","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-11-133","article-title":"Crystal structure of the lytic CHAPK domain of the endolysin LysK from staphylococcus aureus bacteriophage K","volume":"11","author":"Sanz-Gaitero","year":"2014","journal-title":"Virology Journal"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib191","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/AEM.01616-06","article-title":"Lytic activity of recombinant bacteriophage \u03c611 and \u03c612 endolysins on whole cells and biofilms of Staphylococcus aureus","volume":"73","author":"Sass","year":"2007","journal-title":"Applied and Environmental Microbiology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib192","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/ijms20030716","article-title":"In vitro activity of the bacteriophage endolysin HY-133 against staphylococcus aureus small-colony variants and their corresponding wild types","volume":"20","author":"Schleimer","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.09.001_bib193","doi-asserted-by":"crossref","DOI":"10.2217\/fmb.12.97","article-title":"Bacteriophage endolysins as novel antimicrobials","volume":"7","author":"Schmelcher","year":"2012","journal-title":"Future Microbiology"},{"issue":"2\u20133","key":"10.1016\/bs.apcsb.2025.09.001_bib194","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jbiotec.2012.09.010","article-title":"Staphylococcus haemolyticus prophage \u03a6SH2 endolysin relies on cysteine, histidine-dependent amidohydrolases\/peptidases activity for lysis \u2018from without","volume":"162","author":"Schmelcher","year":"2012","journal-title":"Journal of Biotechnology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.09.001_bib195","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/AEM.07050-11","article-title":"Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing staphylococcus aureus in murine mammary glands","volume":"78","author":"Schmelcher","year":"2012","journal-title":"Applied and Environmental Microbiology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib196","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/jac\/dku552","article-title":"Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection","volume":"70","author":"Schmelcher","year":"2015","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.09.001_bib197","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02666-16","article-title":"Bacteriophage lysin CF-301, a potent antistaphylococcal biofilm agent","volume":"61","author":"Schuch","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6900","key":"10.1016\/bs.apcsb.2025.09.001_bib198","doi-asserted-by":"crossref","DOI":"10.1038\/nature01026","article-title":"A bacteriolytic agent that detects and kills bacillus anthracis","volume":"418","author":"Schuch","year":"2002","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib199","doi-asserted-by":"crossref","unstructured":"Schuch, R., Lee, H.M., Schneider, B.C., Sauve, K.L., Law, C., Khan, B.K., & Wittekind, M. (2013). Combination Therapy with Lysin CF301 and Antibiotic is Superior to Antibiotic Alone for Treating MRSA Induced Murine Bacteremia.","DOI":"10.1093\/infdis\/jit637"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib200","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10030245","article-title":"A putative amidase endolysin encoded by clostridium perfringens St13 exhibits specific lytic activity and synergizes with the muramidase endolysin psm","volume":"10","author":"Sekiya","year":"2021","journal-title":"Antibiotics"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.09.001_bib201","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00482-20","article-title":"Effect of the lysin exebacase on cardiac vegetation progression in a rabbit model of Methicillin-resistant staphylococcus aureus endocarditis as determined by echocardiography","volume":"64","author":"Shah","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib202","doi-asserted-by":"crossref","DOI":"10.1039\/D0SC04394J","article-title":"Structural basis for recognition of bacterial cell wall teichoic acid by pseudo-symmetric SH3b-like repeats of a viral peptidoglycan hydrolase","volume":"12","author":"Shen","year":"2021","journal-title":"Chemical Science"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00284-012-0119-2","article-title":"Combined antibacterial activity of phage lytic proteins holin and lysin from streptococcus suis bacteriophage SMP","volume":"65","author":"Shi","year":"2012","journal-title":"Current Microbiology"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib204","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1128\/AAC.00126-14","article-title":"Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from staphylococcus aureus endophthalmitis","volume":"58","author":"Singh","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2024.102433","article-title":"Gram-negative endolysins: Overcoming the outer membrane obstacle","volume":"78","author":"Sisson","year":"2024","journal-title":"Current Opinion in Microbiology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib206","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01781-20","article-title":"Engineering of long-circulating peptidoglycan hydrolases enables efficient treatment of systemic staphylococcus aureus infection","volume":"11","author":"Sobieraj","year":"2020","journal-title":"MBio"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.09.001_bib207","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/antibiotics9120906","article-title":"Simultaneous control of staphylococcus aureus and bacillus cereus using a hybrid endolysin LysB4EAD-LysSA11","volume":"9","author":"Son","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.615887","article-title":"Development of a novel chimeric endolysin, Lys109 with enhanced lytic activity against staphylococcus aureus","volume":"11","author":"Son","year":"2021","journal-title":"Frontiers in Microbiology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.09.001_bib209","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00253-009-2386-9","article-title":"Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme","volume":"86","author":"Son","year":"2010","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib210","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/jb.107.2.499-504.1971","article-title":"Staphylococcal bacteriophage-associated lysin: A lytic agent active against Staphylococcus aureus","volume":"107","author":"Sonstein","year":"1971","journal-title":"Journal of Bacteriology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.09.001_bib211","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/antibiotics10101186","article-title":"An enzybiotic regimen for the treatment of methicillin-resistant staphylococcus aureus orthopaedic device-related infection","volume":"10","author":"Sumrall","year":"2021","journal-title":"Antibiotics"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.09.001_bib212","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02723-20","article-title":"Exebacase is active In Vitro in pulmonary surfactant and is efficacious alone and synergistic with daptomycin in a mouse model of lethal staphylococcus aureus lung infection","volume":"65","author":"Swift","year":"2021","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.09.001_bib213","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1099\/mic.0.27937-0","article-title":"Functional analysis of the lysis genes of Staphylococcus aureus phage P68 in Escherichia coli","volume":"151","author":"Tak\u00e1\u010d","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib214","doi-asserted-by":"crossref","first-page":"139630","DOI":"10.1016\/j.ijbiomac.2025.139630","article-title":"Exploring in vitro efficacy of rCHAPk with antibiotic combinations, and promising findings of its therapeutic potential for clinical-originated MRSA wound infection","volume":"296","author":"Tasdurmazli","year":"2025","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib215","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-pathol-012615-044351","article-title":"Pathogenesis of staphylococcus aureus bloodstream infections","volume":"11","author":"Thomer","year":"2016","journal-title":"Annual Review of Pathology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib216","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clinical Microbiology Reviews"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib217","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s13063-017-2118-x","article-title":"Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: Study protocol for a randomized controlled trial (MAAS trial)","volume":"18","author":"Tott\u00e9","year":"2017","journal-title":"Trials"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib218","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000473872","article-title":"Successful treatment of chronic staphylococcus aureus-Related dermatoses with the topical endolysin staphefekt SA.100: A report of 3 cases","volume":"9","author":"Tott\u00e9","year":"2017","journal-title":"Case Reports in Dermatology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.09.001_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2019.114879","article-title":"In vitro activity of exebacase (CF-301) against clinical staphylococcus aureus surveillance isolates from the United States, Europe, and latin america, 2015\u20132017","volume":"95","author":"Traczewski","year":"2019","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"4814","key":"10.1016\/bs.apcsb.2025.09.001_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(01)20383-3","article-title":"An investigation on the nature of ultra-microscopic viruses","volume":"186","author":"Twort","year":"1915","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib221","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00203-024-04003-6","article-title":"Assessing the synergistic potential of bacteriophage endolysins and antimicrobial peptides for eradicating bacterial biofilms","volume":"206","author":"Tyagi","year":"2024","journal-title":"Archives of Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib222","unstructured":"UF study: Silent MRSA carriers have twice the mortality rate of adults without the bacteria - UF Health. (2025, July 18). https:\/\/ufhealth.org\/news\/2021\/uf-study-silent-mrsa-carriers-have-twice-mortality-rate-adults-without-bacteria."},{"key":"10.1016\/bs.apcsb.2025.09.001_bib223","unstructured":"University Hospital Tuebingen. (2024). A randomized double-blind Placebo-controlled first-in-man single-dose and multiple dose study to evaluate the safety, tolerability and efficacy of a recombinant chimeric bacteriophage endolysin HY-133 with an extended phase to evaluate effects of the nasal microbiome (Clinical Trial Registration No. NCT06290557). clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT06290557."},{"issue":"15","key":"10.1016\/bs.apcsb.2025.09.001_bib224","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.2023021671","article-title":"Staphylococcus aureusinduces drug resistance in cancer T cells in S\u00e9zary syndrome","volume":"143","author":"Vadivel","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib225","doi-asserted-by":"crossref","DOI":"10.1111\/j.1574-6976.2007.00094.x","article-title":"Peptidoglycan structure and architecture","volume":"32","author":"Vollmer","year":"2008","journal-title":"FEMS Microbiology Reviews"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.09.001_bib226","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1128\/AAC.47.11.3613-3615.2003","article-title":"In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood","volume":"47","author":"Von Eiff","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib227","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pep.2018.03.014","article-title":"Rapid purification of bacteriophage endolysin TSPphg and its exogenous treatment could act as an alternative bacterial cell disruption method","volume":"148","author":"Wang","year":"2018","journal-title":"Protein Expression and Purification"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib228","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/v12020192","article-title":"TSPphg lysin from the extremophilic thermus bacteriophage TSP4 as a potential antimicrobial agent against both Gram-Negative and Gram-positive pathogenic bacteria","volume":"12","author":"Wang","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib229","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/j.1365-2672.2008.03953.x","article-title":"Identification and characterization of the two-component cell lysis cassette encoded by temperate bacteriophage \u03d5 PYB5 of Lactobacillus fermentum","volume":"105","author":"Wang","year":"2008","journal-title":"Journal of Applied Microbiology"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.09.001_bib230","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00380-18","article-title":"A phage lysin fused to a cell-penetrating peptide kills intracellular methicillin-resistant staphylococcus aureus in keratinocytes and has potential as a treatment for skin infections in mice","volume":"84","author":"Wang","year":"2018","journal-title":"Applied and Environmental Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib231","doi-asserted-by":"crossref","first-page":"1304932","DOI":"10.3389\/fmicb.2023.1304932","article-title":"Bacteriophage endolysin Ply113 as a potent antibacterial agent against polymicrobial biofilms formed by enterococci and Staphylococcus aureus","volume":"14","author":"Wang","year":"2023","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib232","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1146\/annurev.micro.54.1.799","article-title":"Holins: The protein clocks of bacteriophage infections","volume":"54","author":"Wang","year":"2000","journal-title":"Annual Review of Microbiology"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib233","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00284-009-9379-x","article-title":"Purified recombinant phage lysin LySMP: An extensive spectrum of lytic activity for swine streptococci","volume":"58","author":"Wang","year":"2009","journal-title":"Current Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib234","article-title":"Sequence analysis of a Staphylococcus aureus gene encoding a peptidoglycan","author":"Wang","year":"1991","journal-title":"Gene-Combis"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib235","doi-asserted-by":"crossref","first-page":"821989","DOI":"10.3389\/fmicb.2022.821989","article-title":"Bacteriophage lytic enzyme P9ly as an alternative antibacterial agent against antibiotic-resistant shigella dysenteriae and staphylococcus aureus","volume":"13","author":"Wang","year":"2022","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib236","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12985-020-01403-0","article-title":"MMPphg from the thermophilic Meiothermus bacteriophage MMP17 as a potential antimicrobial agent against both Gram-negative and Gram-positive bacteria","volume":"17","author":"Wang","year":"2020","journal-title":"Virology Journal"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2020.105676","article-title":"High cell-density fermentation, expression and purification of bacteriophage lysin TSPphg, a thermostable antimicrobial protein from extremophilic thermus bacteriophage TSP4","volume":"174","author":"Wang","year":"2020","journal-title":"Protein Expression and Purification"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.09.001_bib238","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01078-19","article-title":"Antimicrobial activity of exebacase (Lysin CF-301) against the most common causes of infective endocarditis","volume":"63","author":"Watson","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib239","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01885-19","article-title":"Exebacase demonstrates In Vitro synergy with a broad range of antibiotics against both Methicillin-Resistant and Methicillin-Susceptible staphylococcus aureus","volume":"64","author":"Watson","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2025.09.001_bib240","first-page":"9","article-title":"Sequence analysis of the region upstream of a peptidoglycan hydrolase-encoding gene from bacteriophage AE11 of Staphylococcus aureus","volume":"133","author":"Weerakoon","year":"1995","journal-title":"FEMS Microbiology Letters"},{"issue":"5650","key":"10.1016\/bs.apcsb.2025.09.001_bib241","doi-asserted-by":"crossref","DOI":"10.1126\/science.1090956","article-title":"Genetic analysis of a high-level vancomycin-resistant isolate of staphylococcus aureus","volume":"302","author":"Weigel","year":"2003","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijfoodmicro.2025.111110","article-title":"Characterization of a phage endolysin LysLFP01 and its antibacterial activity","volume":"432","author":"Wen","year":"2025","journal-title":"International Journal of Food Microbiology"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib243","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.jid.2024.01.018","article-title":"Selective depletion of staphylococcus aureus restores the skin microbiome and accelerates tissue repair after injury","volume":"144","author":"Wilkinson","year":"2024","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib244","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.935145","article-title":"Endolysins against streptococci as an antibiotic alternative","volume":"13","author":"Wong","year":"2022","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib245","article-title":"iNtRON signs licence deal with basilea for antibacterial bio-drug SAL200","author":"World Pharmaceutical","year":"2023","journal-title":"World Pharmaceutical Frontiers"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib246","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.3389\/fmicb.2018.03302","article-title":"A Novel Phage PD-6A3, and its endolysin Ply6A3, with extended lytic activity against acinetobacter baumannii","volume":"9","author":"Wu","year":"2019","journal-title":"Frontiers in Microbiology"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.09.001_bib247","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1128\/AAC.47.11.3407-3414.2003","article-title":"Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces","volume":"47","author":"Wu","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib248","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/AEM.02581-15","article-title":"Combination therapy of LysGH15 and apigenin as a new strategy for treating pneumonia caused by staphylococcus aureus","volume":"82","author":"Xia","year":"2016","journal-title":"Applied and Environmental Microbiology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib249","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.3168\/jds.2020-19456","article-title":"The application of the lytic domain of endolysin from staphylococcus aureus bacteriophage in milk","volume":"104","author":"Yan","year":"2021","journal-title":"Journal of Dairy Science"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib250","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3389\/fmicb.2018.01778","article-title":"Antibacterial activity of a lytic enzyme encoded by pseudomonas aeruginosa double stranded RNA bacteriophage phiYY","volume":"9","author":"Yang","year":"2018","journal-title":"Frontiers in Microbiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib251","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01610-19","article-title":"Linker editing of pneumococcal lysin ClyJ conveys improved bactericidal activity","volume":"64","author":"Yang","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.09.001_bib252","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798045","article-title":"Staphylococcus aureus virulence attenuation and immune clearance mediated by a phage lysin\u2010derived protein","volume":"37","author":"Yang","year":"2018","journal-title":"The EMBO Journal"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.09.001_bib253","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/08927014.2014.905927","article-title":"Degradation of methicillin-resistant Staphylococcus aureus biofilms using a chimeric lysin","volume":"30","author":"Yang","year":"2014","journal-title":"Biofouling"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib254","article-title":"A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant staphylococcus aureus","volume":"7","author":"Yang","year":"2017","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib255","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/AAC.01793-13","article-title":"Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant staphylococcus aureus In Vitro and In Vivo","volume":"58","author":"Yang","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.09.001_bib256","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1021\/acsinfecdis.4c00039","article-title":"Uncovering endolysins against methicillin-resistant staphylococcus aureus using a microbial single-cell genome database","volume":"10","author":"Yoda","year":"2024","journal-title":"ACS Infectious Diseases"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.09.001_bib257","article-title":"Phage lysis: three steps, three choices, one outcome","volume":"52","author":"Young","year":"2014","journal-title":"Journal of Microbiology (Seoul, Korea)"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.09.001_bib258","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.4014\/jmb.1908.08021","article-title":"Characteristics and lytic activity of phage-derived peptidoglycan hydrolase, LysSAP8, as a potent alternative biocontrol agent for staphylococcus aureus","volume":"29","author":"Yu","year":"2019","journal-title":"Journal of Microbiology and Biotechnology"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.09.001_bib259","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s12275-021-1242-1","article-title":"Characterization of staphylococcal endolysin LysSAP33 possessing untypical domain composition","volume":"59","author":"Yu","year":"2021","journal-title":"Journal of Microbiology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.09.001_bib260","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/1751-7915.13594","article-title":"The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity","volume":"14","author":"Yuan","year":"2021","journal-title":"Microbial Biotechnology"},{"issue":"15","key":"10.1016\/bs.apcsb.2025.09.001_bib261","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00886-18","article-title":"Antibacterial effects of phage lysin LysGH15 on planktonic cells and biofilms of diverse staphylococci","volume":"84","author":"Zhang","year":"2018","journal-title":"Applied and Environmental Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib262","article-title":"LysGH15 kills staphylococcus aureus without being affected by the humoral immune response or inducing inflammation","volume":"6","author":"Zhang","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib263","article-title":"Therapeutic efficacy of LysGH15 against necrotising pneumonia caused by staphylococcus aureus in a rabbit model","volume":"12","author":"Zhang","year":"2025","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib264","doi-asserted-by":"crossref","first-page":"856473","DOI":"10.3389\/fmicb.2022.856473","article-title":"Characterization and genomic analysis of a novel jumbo bacteriophage vB_StaM_SA1 infecting staphylococcus aureus with two lysins","volume":"13","author":"Zhang","year":"2022","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.09.001_bib265","article-title":"Coordinated peptidoglycan synthases and hydrolases stabilize the bacterial cell wall","volume":"14","author":"Zhang","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116727","article-title":"Engineering the bacteriophage 80 alpha endolysin as a fast and ultrasensitive detection toolbox against Staphylococcus aureus","volume":"266","author":"Zhao","year":"2024","journal-title":"Biosensors and Bioelectronics"},{"key":"10.1016\/bs.apcsb.2025.09.001_bib267","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.rvsc.2017.02.011","article-title":"The lytic activity of recombinant phage lysin LysK\u0394amidase against staphylococcal strains associated with bovine and human infections in the jiangsu province of China","volume":"111","author":"Zhou","year":"2017","journal-title":"Research in Veterinary Science"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Antimicrobial Peptides and Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:21:43Z","timestamp":1769185303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162325000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345197"],"references-count":267,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2025.09.001","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}